Hungarian researchers develop antibiotics against MRSA ʼsuper bugʼ
Photo by Viacheslav Lopatin/Shutterstock.com
The Biological Research Center of Szeged has developed antibiotic molecules that could be an effective treatment for the MRSA "super bug", according to a report by state news wire MTI.
Photo by Viacheslav Lopatin/Shutterstock.com
The molecules, dubbed ULD1 and ULD2, target several areas in the cell of the drug-resistant MRSA bacteria.
The team of researchers who developed the molecules are headed by Csaba Pál and worked in close cooperation with Lucija Peterlin of the University of Ljubljana.
Czech Economic Sentiment Hits 1-year High
Chinese President to Visit Budapest in May
Hungarian Gen Z Auto-buyers Prioritize Affordability
Liz & Chain Rooftop Bar Debuts Sustainable Cocktails
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
